Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.

Saved in:
Bibliographic Details
Title: Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare.
Authors: Ughi N; Multispecialist Medical Department, Division of Rheumatology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. nicola.ughi@ospedaleniguarda.it., Del Gaudio F, Dicuonzo A, Orso M, Micheloni G, Puoti M, Pani A, Scaglione F, Zoppini L, Rossetti C, Epis OM, Bellavia G, Giroldi S, Moreno M, Bosio M
Source: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2021 Dec; Vol. 25 (24), pp. 7985-7996.
Publication Type: Journal Article
Journal Info: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2284-0729
DOI:10.26355/eurrev_202112_27649